Total Payments
$1,235
2024 Payments
$165.87
Companies
12
Transactions
52
Medicare Patients
4,335
Medicare Billing
$285,848
Payment Breakdown by Category
Food & Beverage$1,190 (96.4%)
Gifts$45.00 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,190 | 51 | 96.4% |
| Gift | $45.00 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $453.44 | 15 | $0 (2024) |
| Allergan, Inc. | $245.62 | 13 | $0 (2021) |
| Oyster Point Pharma, Inc. | $122.58 | 6 | $0 (2023) |
| Sight Sciences, Inc. | $99.23 | 3 | $0 (2020) |
| Tarsus Pharmaceuticals, Inc. | $87.89 | 4 | $0 (2024) |
| Shire North American Group Inc | $60.17 | 3 | $0 (2017) |
| Kala Pharmaceuticals, Inc. | $44.91 | 2 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $42.95 | 2 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $26.10 | 1 | $0 (2017) |
| Ocular Therapeutix, Inc. | $18.79 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $165.87 | 7 | Tarsus Pharmaceuticals, Inc. ($87.89) |
| 2023 | $415.45 | 14 | AbbVie Inc. ($290.73) |
| 2022 | $141.37 | 7 | ABBVIE INC. ($84.73) |
| 2021 | $76.56 | 4 | Kala Pharmaceuticals, Inc. ($44.91) |
| 2020 | $170.86 | 6 | Allergan, Inc. ($89.27) |
| 2019 | $105.86 | 6 | Allergan Inc. ($69.43) |
| 2018 | $35.07 | 2 | Allergan Inc. ($35.07) |
| 2017 | $124.24 | 6 | Shire North American Group Inc ($60.17) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/24/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: EYE CARE | ||||||
| 09/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/25/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: EYE CARE | ||||||
| 06/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/25/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: EYE CARE | ||||||
| 12/21/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: EYE CARE | ||||||
| 11/15/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: EYE CARE | ||||||
| 11/07/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Ophthalmology | ||||||
| 10/24/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: DRY EYE | ||||||
| 09/14/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $125.39 | General |
| Category: EYE CARE | ||||||
| 09/01/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: EYE CARE | ||||||
| 06/02/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: EYE CARE | ||||||
| 05/22/2023 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $15.83 | General |
| 05/09/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: DRY EYE | ||||||
| 02/22/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: EYE CARE | ||||||
| 02/13/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: DRY EYE | ||||||
| 02/08/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: EYE CARE | ||||||
| 01/25/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: DRY EYE | ||||||
| 01/20/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: EYE CARE | ||||||
| 12/20/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: GLAUCOMA | ||||||
| 09/08/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: GLAUCOMA | ||||||
| 08/24/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: DRY EYE | ||||||
| 08/16/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: GLAUCOMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,346 | 1,887 | $180,115 | $86,315 |
| 2022 | 10 | 1,326 | 1,858 | $178,620 | $88,042 |
| 2021 | 13 | 1,240 | 1,720 | $166,040 | $94,657 |
| 2020 | 7 | 423 | 542 | $50,030 | $16,833 |
Total Patients
4,335
Total Services
6,007
Medicare Billing
$285,848
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 278 | 281 | $43,555 | $26,453 | 60.7% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 364 | 817 | $40,850 | $17,999 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 169 | $27,040 | $17,150 | 63.4% |
| 92250 | Photography of the retina | Office | 2023 | 260 | 263 | $30,245 | $7,896 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 79 | $9,085 | $5,413 | 59.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 87 | 93 | $9,300 | $2,763 | 29.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 27 | 27 | $5,400 | $2,599 | 48.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 35 | 36 | $4,320 | $1,825 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,400 | $1,485 | 61.9% |
| 92134 | Imaging of retina | Office | 2023 | 43 | 44 | $4,400 | $1,246 | 28.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,200 | $753.68 | 62.8% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 17 | 34 | $1,360 | $384.20 | 28.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 16 | 16 | $960.00 | $348.60 | 36.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 276 | 278 | $43,090 | $26,831 | 62.3% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 361 | 818 | $40,900 | $18,174 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 142 | $22,750 | $14,544 | 63.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 123 | $14,145 | $8,348 | 59.0% |
| 92250 | Photography of the retina | Office | 2022 | 236 | 239 | $27,485 | $7,540 | 27.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 50 | 50 | $9,550 | $4,926 | 51.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 88 | 95 | $9,500 | $2,589 | 27.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 35 | 35 | $4,200 | $1,943 | 46.3% |
| 92134 | Imaging of retina | Office | 2022 | 45 | 46 | $4,600 | $1,694 | 36.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 32 | $2,400 | $1,453 | 60.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 259 | 259 | $40,145 | $27,975 | 69.7% |
| 83861 | Microfluid analysis of tears | Office | 2021 | 354 | 782 | $39,100 | $17,565 | 44.9% |
About Dr. Stephen Solomon, MD
Dr. Stephen Solomon, MD is a Ophthalmology healthcare provider based in Greenbelt, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487643144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Solomon, MD has received a total of $1,235 in payments from pharmaceutical and medical device companies, with $165.87 received in 2024. These payments were reported across 52 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,190).
As a Medicare-enrolled provider, Solomon has provided services to 4,335 Medicare beneficiaries, totaling 6,007 services with total Medicare billing of $285,848. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Greenbelt, MD
- Active Since 10/17/2005
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1487643144
Products in Payments
- DURYSTA (Drug) $558.13
- TYRVAYA (Drug) $122.58
- OMNI (Device) $99.23
- XDEMVY (Drug) $87.89
- RESTASIS (Drug) $87.26
- XIIDRA (Drug) $60.17
- INVELTYS (Drug) $44.91
- Cequa (Drug) $42.95
- COMBIGAN (Drug) $29.73
- BESIVANCE (Drug) $26.10
- LUMIGAN (Drug) $23.94
- ReSure Sealant (Device) $18.79
- Avenova (Device) $17.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Greenbelt
Mr. Jonathan Solomon, Md, MD
Ophthalmology — Payments: $175,462
Ophthalmology $175,462
Dr. Reginald Sanders, M.d, M.D
Ophthalmology — Payments: $25,511
Ophthalmology $25,511
Joshua Levinson
Ophthalmology — Payments: $4,825
Ophthalmology $4,825
Jason Huang, Md, MD
Ophthalmology — Payments: $3,443
Ophthalmology $3,443
Sarah Chang, Md, MD
Ophthalmology — Payments: $2,183
Ophthalmology $2,183
Dr. Geoffrey Kaplan, M.d, M.D
Ophthalmology — Payments: $1,541
Ophthalmology $1,541